These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21724051)

  • 1. INF α2b for ocular squamous neoplasia.
    Espandar L; Kassem J
    Ophthalmology; 2011 Jul; 118(7):1485; author reply 1485-6. PubMed ID: 21724051
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b.
    Esquenazi S; Fry CL; Holley E
    Br J Ophthalmol; 2005 Sep; 89(9):1221. PubMed ID: 16113387
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conjunctival squamous cell carcinoma: paradoxical response to interferon eyedrops].
    Mata E; Conesa E; Castro M; Martínez L; de Pablo C; González ML
    Arch Soc Esp Oftalmol; 2014 Jul; 89(7):293-6. PubMed ID: 24269461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
    Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
    Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
    Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC
    Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis].
    Torres Suárez E; Pinheiro R; Schrage N
    Ophthalmologe; 2017 Feb; 114(2):155-158. PubMed ID: 27300720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.
    Huerva V; Mangues I
    J Fr Ophtalmol; 2008 Mar; 31(3):317-25. PubMed ID: 18404128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha-2b in giant ocular surface squamous neoplasia.
    Hernandez-Bogantes E; Serna-Ojeda JC; Lichtinger A; Graue-Hernández EO
    Indian J Ophthalmol; 2016 May; 64(5):393-4. PubMed ID: 27380981
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular surface toxicity associated with topical interferon alpha-2b.
    Aldave AJ; Nguyen A
    Br J Ophthalmol; 2007 Aug; 91(8):1087-8. PubMed ID: 17638822
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoreduction of locally advanced orbito-conjunctival squamous cell carcinoma with intraorbital interferon alpha-2b injection: a globe saving approach.
    Meel R; Dhiman R; Sen S; Sharma S
    Clin Exp Ophthalmol; 2018 Jan; 46(1):87-88. PubMed ID: 28570760
    [No Abstract]   [Full Text] [Related]  

  • 11. Resolution of recurrent conjunctival papilloma after topical and intralesional interferon alpha2b with partial excision in a child.
    Kothari M; Mody K; Chatterjee D
    J AAPOS; 2009 Oct; 13(5):523-5. PubMed ID: 19840738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.
    Kaliki S; Singh S; Iram S; Tripuraneni D
    Indian J Ophthalmol; 2016 Oct; 64(10):702-709. PubMed ID: 27905329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia: A Literature-Based Decision Analysis.
    Siedlecki AN; Tapp S; Tosteson AN; Larson RJ; Karp CL; Lietman T; Zegans ME
    Cornea; 2016 May; 35(5):613-8. PubMed ID: 26890663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia.
    Kabra NS; Patil VS; Dhanuka DG
    Indian J Ophthalmol; 2021 Dec; 69(12):3776-3777. PubMed ID: 34827049
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment with topical interferon alone in severe conjunctivo-corneal neoplasia].
    Díaz-Valle D; Benítez-del-Castillo JM; Díaz-Valle T; Poza-Morales Y; Arteaga-Sánchez A
    Arch Soc Esp Oftalmol; 2005 Dec; 80(12):729-32. PubMed ID: 16372217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term administration of topical interferon alfa-2beta in the treatment of conjunctival squamous papilloma.
    Morgenstern KE; Givan J; Wiley LA
    Arch Ophthalmol; 2003 Jul; 121(7):1052-3. PubMed ID: 12860816
    [No Abstract]   [Full Text] [Related]  

  • 19. Histologic Changes in a Squamous Cell Carcinoma of Conjunctiva Refractive to Interferon-α2b.
    Rodriguez ME; Burris CK; Saipe NB
    Ophthalmology; 2016 Jan; 123(1):190. PubMed ID: 26707439
    [No Abstract]   [Full Text] [Related]  

  • 20. [Topical interferon alpha 2 beta therapy in the management of conjunctival intraepithelial neoplasia].
    Albornoz López R; Fernández García MI; Pérez Rodrigo I
    Farm Hosp; 2007; 31(6):382-4. PubMed ID: 18348671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.